Maynard Um
-
-
-
-
-
-
-
Fulcrum Therapeutics (FULC) PT Raised to $18 at Truist Securities
-
-
-
-
-
-
-
Fulcrum Therapeutics (FULC) PT Raised to $24 at Leerink Partners
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Fulcrum Therapeutics (FULC)
-
-
-
-
-
-
-
Fulcrum Therapeutics reports Q2 results, pociredir trial data
-
-
-
-
-
-
-
Stifel Downgrades Fulcrum Therapeutics (FULC) to Hold
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

